A 12-Week, Randomized, Placebo- and Active-Comparator-Controlled, Parallel-Group, Double-Blind Study to Assess the Safety and Efficacy of Etoricoxib 30 mg Versus Ibuprofen 2400 mg in Patients With Osteoarthritis (Study 2)

Organon and Co0 个研究点目标入组 548 人开始时间: 2003年4月9日最近更新: 2024年8月15日

适应症

试验速览

阶段: 3 期
状态: 已完成
发起方: Organon and Co
入组人数: 548
主要终点: WOMAC VA 3.0 pain subscale, WOMAC VA 3.0 physical function subscale, and Patient Global Assessment of Disease Status Scale. Efficacy data collected at Weeks 2, 4, 8, and 12.

研究概览研究设计入排标准结局指标研究者记录与标识符相似试验

研究概览

简要总结

This study was conducted to assess the safety and tolerability of an investigational drug and to evaluate its effectiveness in the treatment of osteoarthritis of the hip or knee in both men and women.

详细描述

The duration of treatment is 12 weeks.

研究设计

研究类型: Interventional
分配方式: Randomized
干预模型: Parallel
主要目的: Treatment
盲法: Double (Participant, Investigator)

入排标准

年龄范围: 40 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•Patients with osteoarthritis of the hip or knee who use current approved medication (nonsteroidal anti-inflammatory drugs (NSAIDs)) or tylenol to treat the symptoms of their osteoarthritis. Patients taking NSAIDs are required to discontinue using these drugs and their symptoms must become worse.

排除标准

•Patients with certain medical conditions may not be allowed to participate. These conditions will be reviewed with the study physician.

结局指标

主要结局

WOMAC VA 3.0 pain subscale, WOMAC VA 3.0 physical function subscale, and Patient Global Assessment of Disease Status Scale. Efficacy data collected at Weeks 2, 4, 8, and 12.

次要结局

Patient Global Assessment of Response to Therapy, Investigator Global Assessment of Disease Status, Womac VA 3.0: Stiffness, Overall Average Score and Overall Subscale Average. Clinical efficacy data collected at Weeks 2, 4, 8, and 12.

研究者

发起方

Organon and Co

申办方类型

Industry

责任方

Sponsor

相似试验

已完成

3 期

A Study to Assess the Safety and Efficacy of an Investigational Drug in Patients With Osteoarthritis (0663-071)(COMPLETED)Osteoarthritis

NCT00269191Organon and Co528

已完成

2 期

A Study to Evaluate the Safety and Efficacy of an Investigational Drug in the Treatment of Postoperative Dental Pain (MK-2295-005)Pain, PostoperativeTooth Extraction

NCT00387140Merck Sharp & Dohme LLC89

已完成

3 期

A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-076)(COMPLETED)Osteoarthritis

NCT00092768Organon and Co500

已完成

3 期

A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-077)(COMPLETED)Osteoarthritis

NCT00092781Organon and Co500

已完成

3 期

A Study of the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia.Schizophrenia

NCT04115319Otsuka Pharmaceutical Development & Commercialization, Inc.305